The CD161+CD39+ co-expression pattern appears particularly effective for identifying Th17-enriched populations, with these cells displaying characteristic Th17 markers (CCR6, IL-23R) and serving as useful indicators of Th17 activity in Crohn’s disease (23). This evidence concerns the gene IL23R and Crohn disease.